Calliditas Therapeutics
(NASDAQ:CALT)
$19.49
-1.04[-5.07%]
At close: Apr 12
$19.49
0[0.00%]
After Hours: 9:23AM EDT
Consensus Rating1
Buy
Highest Price Target1
$79.00
Lowest Price Target1
$18.00
Consensus Price Target1
$49.25

Calliditas Therapeutics Stock (NASDAQ:CALT), Analyst Ratings, Price Targets, Predictions

Calliditas Therapeutics AB has a consensus price target of $49.25, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on February 22, 2024, November 27, 2023, and October 16, 2023. With an average price target of $50 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 156.54% upside for Calliditas Therapeutics AB from these 3 analyst ratings.

Analyst Trend
1
Oct 23
1
Nov 23
1
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
HC Wainwright & Co.
Guggenheim
Citigroup

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Calliditas Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/22/2024CALTBuy Now
Calliditas Therapeutics
$19.49156.54%HC Wainwright & Co.
Arthur He
→ $50ReiteratesBuy → BuyGet Alert
11/27/2023CALTBuy Now
Calliditas Therapeutics
$19.49156.54%HC Wainwright & Co.
Arthur He
→ $50ReiteratesBuy → BuyGet Alert
10/16/2023CALTBuy Now
Calliditas Therapeutics
$19.49156.54%HC Wainwright & Co.
Edwin Zhang
$50 → $50ReiteratesBuy → BuyGet Alert
08/21/2023CALTBuy Now
Calliditas Therapeutics
$19.49156.54%HC Wainwright & Co.
Edwin Zhang
→ $50ReiteratesBuy → BuyGet Alert
08/18/2023CALTBuy Now
Calliditas Therapeutics
$19.49-7.64%Guggenheim
Vamil Divan
$21 → $18MaintainsNeutralGet Alert
06/20/2023CALTBuy Now
Calliditas Therapeutics
$19.49207.85%HC Wainwright & Co.
Edwin Zhang
→ $60Initiates → BuyGet Alert
03/01/2023CALTBuy Now
Calliditas Therapeutics
$19.49-7.64%Guggenheim
Vamil Divan
→ $18Initiates → NeutralGet Alert
02/24/2023CALTBuy Now
Calliditas Therapeutics
$19.49305.34%Citigroup
Yigal Nochomovitz
$76 → $79MaintainsBuyGet Alert
12/20/2021CALTBuy Now
Calliditas Therapeutics
$19.49218.11%HC Wainwright & Co.
Edwin Zhang
MaintainsBuyGet Alert

FAQ

Q

What is the target price for Calliditas Therapeutics (CALT)?

A

The latest price target for Calliditas Therapeutics (NASDAQ: CALT) was reported by HC Wainwright & Co. on February 22, 2024. The analyst firm set a price target for $50.00 expecting CALT to rise to within 12 months (a possible 156.54% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Calliditas Therapeutics (CALT)?

A

The latest analyst rating for Calliditas Therapeutics (NASDAQ: CALT) was provided by HC Wainwright & Co., and Calliditas Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Calliditas Therapeutics (CALT)?

A

There is no last upgrade for Calliditas Therapeutics.

Q

When was the last downgrade for Calliditas Therapeutics (CALT)?

A

There is no last downgrade for Calliditas Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Calliditas Therapeutics (CALT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calliditas Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calliditas Therapeutics was filed on February 22, 2024 so you should expect the next rating to be made available sometime around February 22, 2025.

Q

Is the Analyst Rating Calliditas Therapeutics (CALT) correct?

A

While ratings are subjective and will change, the latest Calliditas Therapeutics (CALT) rating was a reiterated with a price target of $0.00 to $50.00. The current price Calliditas Therapeutics (CALT) is trading at is $19.49, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch